IAA with CDC for HPTN 052: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples
|
Research Initiative
|
CDC
|
NIAID
|
2009
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR
|
2003
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Implementation Barriers to Screening, Brief Intervention and Referral to Treatment (SBIRT) in Federally Qualified Health Centers (FQHCs)
|
Research Initiative
|
HRSA
|
NIDA
|
2013
|
|
Improving Community Health through Land Reuse
|
Committee, Advisory Group, or Work Group
|
ATSDR
|
NIEHS
|
2013
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCAM
|
2008
|
|
IMS Health Contract
|
Research Initiative
|
CDC
|
NIDA
|
2012
|
|
Industry Wide Exposure Assessment Study of Workers to Carbon Nanotubes and Nanofibers
|
Research Initiative
|
CDC
|
NIEHS
|
2009
|
|
Influenza (Flu) Risk Management Meeting (FRMM)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Influenza Vaccine Manufacturing Improvement Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Inter-Agency Committee on Drug Control (ICDC)
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NIDA
|
1981
|
|
Inter-Agency Working Group on Technology Transfer
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ OER, OD/ OIR/ OTT
|
1990
|
|
Inter-Society Coordinating Committee (ISCC) for Practitioner Education in Genomics
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIGMS, NIMH, NINDS, NLM
|
2013
|
|
Interactive Publications
|
Resource Development
|
CDC
|
NLM
|
2012
|
|
Interactive Training Tool to Teach Health Care Providers About Reducing Prescription Opioid Abuse
|
Research Initiative
|
AHRQ, CDC, FDA, OS, SAMHSA
|
NIDA, NINDS
|
2013
|
|
Interagency Agreement for Communications on Prevention of Underage Tobacco Use
|
Public Education Campaign
|
FDA
|
NCI
|
2012
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA
|
NICHD, NIDCD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Chemical Hazards Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NINDS
|
2007
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAID, NINDS
|
2010
|
|
Interagency Committee on Emergency Medical Services for Children Research (ICER)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NIDCR, NIGMS, NIMH, NINR
|
1998
|
|
Interagency Committee on Human Growth Hormone
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1984
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NCI, NHLBI, NICHD, NIDA
|
1985
|
|
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD
|
1996
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
|